C-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: A prerequisite for replication

Hepatology

Volumn 53, Issue 4, 2011, Pages 1127-1136

  Pfannkuche, Andreas ^a   Büther, Katrin ^a   Karthe, Juliane ^a   Poenisch, Marion ^b   Bartenschlager, Ralf ^b   Trilling, Mirko ^c   Hengel, Hartmut ^c   Willbold, Dieter ^a,d   Häussinger, Dieter ^a   Bode, Johannes Georg ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HERBIMYCIN A; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; PROTEIN KINASE FYN; PROTEIN KINASE YES; PROTEIN SH2; PROTEIN SH3; PROTEIN TYROSINE KINASE; RNA DIRECTED RNA POLYMERASE; SMALL INTERFERING RNA; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE SILENCING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS REPLICATION;

BENZOQUINONES; CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; LACTAMS, MACROCYCLIC; RNA REPLICASE; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 79953763859     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24214     Document Type: Article

References (21)

1. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095-2100.
2. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-113.
3. Nakagawa S, Umehara T, Matsuda C, Kuge S, Sudoh M, Kohara M. Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice. Biochem Biophys Res Commun 2007; 353: 882-888.
4. Brenndörfer ED, Karthe J, Frelin L, Cebula P, Erhardt A, Schulte am Esch J, et al. Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. HEPATOLOGY 2009; 49: 1810-1820.
5. Bode JG, Brenndorfer ED, Karthe J, Haussinger D. Interplay between host cell and hepatitis C virus in regulating viral replication. Biol Chem 2009; 390: 1013-1032.
6. Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene 2004; 23: 7906-7909.
7. Okutani D, Lodyga M, Han B, Liu M. Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol 2006; 291: L129-L141.
8. Macdonald A, Crowder K, Street A, McCormick C, Harris M. The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 2004; 85: 721-729.
9. Supekova L, Supek F, Lee J, Chen S, Gray N, Pezacki JP, et al. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J Biol Chem 2008; 283: 29-36.
10. Shimakami T, Hijikata M, Luo H, Ma YY, Kaneko S, Shimotohno K, et al. Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon. J Virol 2004; 78: 2738-2748.
11. Kaul A, Woerz I, Meuleman P, Leroux-Roels G, Bartenschlager R. Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant. J Virol 2007; 81: 13168-13179.
12. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 2006; 103: 7408-7413.
13. Uehara Y, Fukazawa H. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol 1991; 201: 370-379.
14. Uehara Y, Hori M, Takeuchi T, Umezawa H. Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol 1986; 6: 2198-2206.
15. Yoneda T, Lowe C, Lee CH, Gutierrez G, Niewolna M, Williams PJ, et al. Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J Clin Invest 1993; 91: 2791-2795.
16. Fukazawa H, Li PM, Yamamoto C, Murakami Y, Mizuno S, Uehara Y. Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro. Biochem Pharmacol 1991; 42: 1661-1671.
17. Shirota Y, Luo H, Qin W, Kaneko S, Yamashita T, Kobayashi K, et al. Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J Biol Chem 2002; 277: 11149-11155.
18. Brugge JS, Erikson RL. Identification of a transformation-specific antigen induced by an avian sarcoma virus. Nature 1977; 269: 346-348.
19. Stehelin D, Varmus HE, Bishop JM, Vogt PK. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 1976; 260: 170-173.
20. Shelton H, Harris M. Hepatitis C virus NS5A protein binds the SH3 domain of the Fyn tyrosine kinase with high affinity: mutagenic analysis of residues within the SH3 domain that contribute to the interaction. Virol J 2008; 5: 24.
21. Macdonald A, Mazaleyrat S, McCormick C, Street A, Burgoyne NJ, Jackson RM, et al. Further studies on hepatitis C virus NS5A-SH3 domain interactions: identification of residues critical for binding and implications for viral RNA replication and modulation of cell signalling. J Gen Virol 2005; 86: 1035-1044.